MoonLake Immunotherapeutics MLTX
11.70 USD +0.23 (+2.01%)
At closeNov 3, 2026, 4:00 PM EST
11.70 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
11.29 Day range 11.72
9.46 52-week range 23.29
- YTD
- -11.23%
- 1 year
- +14.71%
Analyst view
Consensus: buy
Buy
Price target (mean) 28.54 +143.9% upside
Now 11.70
- Target (low)
- 6.00
- Target (mean)
- 28.54
- Target (high)
- 50.00
Ratings (0m) 15 11 buy · 2 hold · 2 sell
- Strong buy1
- Buy10
- Hold2
- Sell2
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 15
- 2 months ago 15
- 3 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.78081 | -0.88 – -0.66 | -1.10 | +29.0% | 0 | 0.0% | 7 |
| Next quarter | -0.81387 | -1.01 – -0.67 | -0.92 | +11.5% | 0 | 0.0% | 7 |
| Current year | -3.38 | -3.67 – -2.91 | -3.53 | +4.3% | 0 | 0.0% | 7 |
| Next year | -3.33 | -4.15 – -2.59 | -3.38 | +1.6% | 19.04M | 0.0% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 13, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 20, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 1, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Jun 9, 2026 | BTIG | Reiterated | Buy | Buy |
| Jun 8, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 12, 2026 | Needham | Maintained | Buy | Buy |
| May 11, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 30, 2026 | BTIG | Reiterated | Buy | Buy |
| Mar 23, 2026 | Wolfe Research | Upgrade | Underperform | Outperform |
| Mar 19, 2026 | Rothschild & Co | Upgrade | Neutral | Buy |
| Mar 11, 2026 | Clear Street | Maintained | Buy | Buy |
| Mar 2, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Mar 2, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 26, 2026 | Needham | Reiterated | Buy | Buy |
| Feb 24, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 23, 2026 | BTIG | Maintained | Buy | Buy |
| Feb 23, 2026 | Needham | Maintained | Buy | Buy |
| Feb 20, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Feb 9, 2026 | BTIG | Reiterated | Buy | Buy |
| Feb 3, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 15, 2026 | Goldman Sachs | Downgrade | Neutral | Sell |
| Jan 9, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 9, 2026 | BTIG | Upgrade | Neutral | Buy |
| Nov 21, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 3, 2025 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Oct 29, 2025 | Citigroup | Downgrade | Neutral | Sell |
| Oct 2, 2025 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Sep 30, 2025 | Guggenheim | Maintained | Buy | Buy |
| Sep 30, 2025 | Wedbush | Maintained | Outperform | Outperform |